# FDA Inspection 1098166 - Vitalant - July 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/0dccf831-dc52-41fe-b4c7-237647cc6a83
Source feed: FDA_Inspections

> FDA Inspection 1098166 for Vitalant on July 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1098166
- Company Name: Vitalant
- Inspection Date: 2019-07-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1214538 - 2023-08-09](https://www.keypedia.com/records/fda_inspections/vitalant/c66b5bca-9e2f-4761-9095-f71cc97c5588)
- [FDA Inspection 1098166 - 2019-07-18](https://www.keypedia.com/records/fda_inspections/vitalant/927060e9-7126-4a14-905d-103591acfe82)
- [FDA Inspection 984109 - 2016-08-18](https://www.keypedia.com/records/fda_inspections/vitalant/1759193c-4199-4e12-bd1e-b0bbe52b2a1b)
- [FDA Inspection 895712 - 2014-09-12](https://www.keypedia.com/records/fda_inspections/vitalant/1251444f-4c62-4139-9739-a79907aba556)
- [FDA Inspection 789482 - 2012-06-22](https://www.keypedia.com/records/fda_inspections/vitalant/04f615a5-3fb1-4429-a20c-7d758aac5c69)

Company: https://www.keypedia.com/companies/vitalant/250dac73-2d2c-4243-8c5b-2e2e387ea86c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d